​

ARS Pharmaceuticals (SPRY) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

ARS Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$89.15M

Latest Revenue (Q)

$568.00K

Main Segment (Y)

Product

ARS Pharmaceuticals Revenue by Period

ARS Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$89.15M297063.33%
2023-12-31$30.00K-97.72%
2022-12-31$1.32M-76.10%
2021-12-31$5.51M-69.13%
2020-12-31$17.84M100.00%
2019-12-31-100.00%
2018-12-31--

ARS Pharmaceuticals generated $89.15M in revenue during NA 2024, up 297063.33% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

ARS Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$568.00K13.60%
2024-06-30$500.00K100.00%
2024-03-31--100.00%
2023-12-31$-30.00K100.00%
2023-09-30--100.00%
2023-06-30$10.00K-50.00%
2023-03-31$20.00K-101.52%
2022-12-31$-1.32M-796.30%
2022-09-30$189.00K-59.27%
2022-06-30$464.00K-30.02%
2022-03-31$663.00K-12.07%
2021-12-31$754.00K42.80%
2021-09-30$528.00K-75.00%
2021-06-30$2.11M-
2021-03-31$2.11M100.00%
2020-12-31--

ARS Pharmaceuticals generated $568.00K in revenue during Q3 2024, up 13.60% compared to the previous quarter, and up 5680.00% compared to the same period a year ago.

ARS Pharmaceuticals Revenue Breakdown

ARS Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Product$7.25M

ARS Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24
Product$6.69M$568.00K

ARS Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

ARS Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WVEWave Life Sciences$108.30M$19.69M
SPRYARS Pharmaceuticals$89.15M$568.00K
CUECue Biopharma$5.49M$3.34M
TCRXTScan Therapeutics$2.82M-
IMMXImmix Biopharma--
ALLRAllarity Therapeutics--
ZURAZura Bio--
CNSPCNS Pharmaceuticals--
CGTXCognition Therapeutics--
ANNXAnnexon--
HEPAHepion Pharmaceuticals--
INABIN8bio--
DRMADermata Therapeutics--
PALIPalisade Bio--
WINTWindtree Therapeutics--

SPRY Revenue FAQ

What is ARS Pharmaceuticals’s yearly revenue?

ARS Pharmaceuticals's yearly revenue for 2024 was $89.15M, representing an increase of 297063.33% compared to 2023. The company's yearly revenue for 2023 was $30K, representing a decrease of -97.72% compared to 2022. SPRY's yearly revenue for 2022 was $1.32M, representing a decrease of -76.10% compared to 2021.

What is ARS Pharmaceuticals’s quarterly revenue?

ARS Pharmaceuticals's quarterly revenue for Q3 2024 was $568K, a 13.60% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $500K, a 100.00% increase from the previous quarter (Q1 2024), and a 4900.00% increase year-over-year (Q2 2023). SPRY's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is ARS Pharmaceuticals’s revenue growth rate?

ARS Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 6674.24%, and for the last 5 years (2020-2024) was 399.85%.

What are ARS Pharmaceuticals’s revenue streams?

ARS Pharmaceuticals's revenue streams in c 24 are Product

What is ARS Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of ARS Pharmaceuticals was Product. This segment made a revenue of $7.26M, representing 100.00% of the company's total revenue.